Fig. 1.
Fig. 1. May-Grünwald-Giemsa–stained cells derived from (A) MACS-selected 97A6+ PB cells (positive enrichment), (B) StemSep (basophil kit)–selected PB cells (negative enrichment), (C) StemSep (basophil kit)–selected PB cells from a patient with accelerated phase CML, and (D) FACS-sorted 97A6+IgE+ BM cells.

May-Grünwald-Giemsa–stained cells derived from (A) MACS-selected 97A6+ PB cells (positive enrichment), (B) StemSep (basophil kit)–selected PB cells (negative enrichment), (C) StemSep (basophil kit)–selected PB cells from a patient with accelerated phase CML, and (D) FACS-sorted 97A6+IgE+ BM cells.

Close Modal

or Create an Account

Close Modal
Close Modal